BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29070037)

  • 21. Carotid-Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus.
    Tougaard NH; Theilade S; Winther SA; Tofte N; Ahluwalia TS; Hansen TW; Rossing P; Frimodt-Møller M
    J Am Heart Assoc; 2020 Oct; 9(19):e017165. PubMed ID: 32955366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Profile of Circulating Matrix Metalloproteinases in Patients Undergoing Lower Limb Endovascular Interventions for Peripheral Arterial Disease.
    Giagtzidis IT; Kadoglou NP; Mantas G; Spathis A; Papazoglou KO; Karakitsos P; Liapis CD; Karkos CD
    Ann Vasc Surg; 2017 Aug; 43():188-196. PubMed ID: 28288884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arterial-ventricular coupling in type 1 diabetes: arterial stiffness is associated with impaired global longitudinal strain in type 1 diabetes patients-the Thousand & 1 Study.
    Theilade S; Rossing P; Jensen JS; Jensen MT
    Acta Diabetol; 2018 Jan; 55(1):21-29. PubMed ID: 29038853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy.
    Jacqueminet S; Ben Abdesselam O; Chapman MJ; Nicolay N; Foglietti MJ; Grimaldi A; Beaudeux JL
    Clin Chim Acta; 2006 May; 367(1-2):103-7. PubMed ID: 16426593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of circulating MMP-2, MMP-1, and TIMP-1 levels with bone biochemical markers and bone mineral density in postmenopausal Chinese women.
    Luo XH; Guo LJ; Shan PF; Xie H; Wu XP; Zhang H; Cao XZ; Yuan LQ; Liao EY
    Osteoporos Int; 2006; 17(4):521-6. PubMed ID: 16365830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial stiffness evaluated by carotid-femoral pulse wave velocity increases the risk of chronic kidney disease in a Chinese population-based cohort.
    Kong X; Ma X; Tang L; Wang Z; Li W; Cui M; Xu D
    Nephrology (Carlton); 2017 Mar; 22(3):205-212. PubMed ID: 26890606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of pulse wave velocity and central pulse pressure in heart failure with reduced ejection fraction.
    Kõre AC; Joonsalu T; Serg M; Pauklin P; Voitk J; Roose I; Eha J; Kampus P
    Blood Press; 2024 Dec; 33(1):2359932. PubMed ID: 38819846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial function, carotid-femoral stiffness, and plasma matrix metalloproteinase-2 in men with bicuspid aortic valve and dilated aorta.
    Tzemos N; Lyseggen E; Silversides C; Jamorski M; Tong JH; Harvey P; Floras J; Siu S
    J Am Coll Cardiol; 2010 Feb; 55(7):660-8. PubMed ID: 20170792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip.
    Masuhara K; Nakai T; Yamaguchi K; Yamasaki S; Sasaguri Y
    Arthritis Rheum; 2002 Oct; 46(10):2625-31. PubMed ID: 12384920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
    Lorenzl S; Buerger K; Hampel H; Beal MF
    Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation.
    Kalogeropoulos AS; Tsiodras S; Rigopoulos AG; Sakadakis EA; Triantafyllis A; Kremastinos DT; Rizos I
    BMC Cardiovasc Disord; 2011 Dec; 11():77. PubMed ID: 22204652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
    Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes may affect the expression of matrix metalloproteinases and their inhibitors more than smoking in chronic periodontitis.
    Bastos MF; Tucci MA; de Siqueira A; de Faveri M; Figueiredo LC; Vallim PC; Duarte PM
    J Periodontal Res; 2017 Apr; 52(2):292-299. PubMed ID: 27363729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation.
    Kozakova M; Morizzo C; Goncalves I; Natali A; Nilsson J; Palombo C
    Cardiovasc Diabetol; 2019 May; 18(1):61. PubMed ID: 31077210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinase -2, -9 and arterial stiffness in children and adolescents: The role of chronic kidney disease, diabetes, and hypertension.
    Stabouli S; Kotsis V; Maliachova O; Printza N; Chainoglou A; Christoforidis A; Taparkou A; Dotis J; Farmaki E; Zafeiriou D
    Int J Cardiol Hypertens; 2020 Mar; 4():100025. PubMed ID: 33447754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aortic-Brachial Pulse Wave Velocity Ratio: A Blood Pressure-Independent Index of Vascular Aging.
    Fortier C; Sidibé A; Desjardins MP; Marquis K; De Serres SA; Mac-Way F; Agharazii M
    Hypertension; 2017 Jan; 69(1):96-101. PubMed ID: 27821616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome.
    Erman H; Gelisgen R; Cengiz M; Tabak O; Erdenen F; Uzun H
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1015-22. PubMed ID: 27049251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
    El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
    Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher HbA
    Tynjälä A; Harjutsalo V; Jansson Sigfrids F; Groop PH; Gordin D;
    Cardiovasc Diabetol; 2023 Mar; 22(1):47. PubMed ID: 36871019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.